Advertisement

Topics

Actelion Pharmaceuticals Ltd Company Profile

14:23 EDT 19th September 2018 | BioPortfolio

Actelion aims to discover or in-license and develop a steady stream of new products as revenue sources, based on first-in class small molecule compounds. In doing so, Actelion is focussing on innovative treatments for high-unmet medical needs, where Actelion’s new drugs can bring therapeutic advantage to patients and economic benefit for the community at large. Pursue comprehensive life cycle and label expansion anagement Actelion aims to develop products to their maximum potential by implementing comprehensive strategies of line extensions and new indications. For example, since gaining approval of Tracleer® in 2001, Actelion has continued to invest in further clinical trials to expand its use into new indications

Location

Hegenheimermattweg 91
Allschwil
Allschwil
4123
Switzerland

Contact

Phone: 41 61 565 65 65
Fax: 41 61 565 65 00
Email: info@dmkzwo.de


News Articles [350 Associated News Articles listed on BioPortfolio]

Helsinn to acquire global rights of Valchlor/Ledaga from Actelion Pharmaceuticals

Helsinn has agreed to acquire worldwide rights to Valchlor/Ledaga (mechlorethamine/chlormethine), an alkylating agent for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-...

Actelion reports positive results from Portico trial for PoPH

Actelion Pharmaceuticals has reported positive outcomes from the Portico trial after meeting the primary endpoint of the study. Portico is...Read More... The post Actelion reports positive results fro...

Helsinn Group to buy worldwide rights of Valchlor/Ledaga from Actelion Pharmaceuticals

Helsinn, a Swiss pharmaceutical group entered into a definitive agreement to acquire worldwide rights to Valchlor/Ledaga (mechlorethamine/chlormethine), an alkylating agent for the topical treatment o...

Helsinn gets global Valchlor/Ledaga rights from Actelion

Johnson & Johnson division Actelion Pharmaceuticals Ltd. granted Helsinn Group global rights to market the topical skin cancer drug Valchlor/Ledaga (mechlorethamine). Financial terms were not disclose...

Wales backs NHS use of Actelion’s Uptravi for PAH

Some patients with pulmonary arterial hypertension (PAH) are now able to access Actelion’s selexipag on the NHS in Wales after a green light from the All Wales Medicines Strategy Group (AWMSG).

Christoph Schmidt, Corporate VP Global Head of Commercial Excellence, Actelion Pharmaceuticals

Christoph Schmidt, Corporate VP Global Head of Commercial Excellence, Actelion Pharmaceuticals

PAH patients in England denied access to Actelion’s Uptravi on NHS

Actelion’s Uptravi will not be funded on the NHS for patients with Pulmonary Arterial Hypertension (PAH), after the drug failed to make it into NHS England’s latest round of specialised co...

Media Service: Hans Ziegler spekulierte auf Actelion und Gategroup

Zürich (ots) - Der Multi-Verwaltungsrat und Industriemanager Hans Ziegler hat mit Insiderwissen unter anderem auf Grossübernahmen von Konzernen wie Actelion und Gategroup an der Börse spekuliert. ....

Drugs and Medications [272 Associated Drugs and Medications listed on BioPortfolio]

Ventavis [Actelion Pharmaceuticals US, Inc.]

These highlights do not include all the information needed to use VENTAVIS safely and effectively. See full prescribing information for VENTAVIS. VENTAVIS (iloprost) inhalation solution Initial U.S. A...

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Veletri [Actelion Pharmaceuticals US, Inc.]

These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI. VELETRI (epoprostenol) for Injection Initial U.S. Approv...

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

PubMed Articles [143 Associated PubMed Articles listed on BioPortfolio]

Azole-based non-peptidomimetic plasmepsin inhibitors.

The spread of drug-resistant malaria parasites urges the search for new antimalarial drugs. Malarial aspartic proteases - plasmepsins (Plms) - are differentially expressed in multiple stages of the Pl...

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Clinical Trials [225 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1332 Associated Companies listed on BioPortfolio]

Actelion Pharmaceuticals Ltd

Actelion aims to discover or in-license and develop a steady stream of new products as revenue sources, based on first-in class small molecule compounds. In doing so, Actelion is focussing on innovati...

Actelion Pharmaceuticals US, Inc.

Actelion Ltd is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland. Actelion's first drug Tracleer® (bosentan), an orally available dual endothelin receptor a...

Actelion

Actelion Ltd, a biopharmaceutical company headquartered in Allschwil / Basel, Switzerland, is a leading player in innovative science related to the endothelium - the single layer of cells separating e...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

OWKIN

OWKIN is a predictive analytics company that utilizes transfer learning to accelerate drug discovery and development. OWKIN’s proprietary platform, OWKIN Plus uses machine le...

More Information about "Actelion Pharmaceuticals Ltd" on BioPortfolio

We have published hundreds of Actelion Pharmaceuticals Ltd news stories on BioPortfolio along with dozens of Actelion Pharmaceuticals Ltd Clinical Trials and PubMed Articles about Actelion Pharmaceuticals Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Actelion Pharmaceuticals Ltd Companies in our database. You can also find out about relevant Actelion Pharmaceuticals Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record